Matinas BioPharma to combine with GH Power, forming new public parent GH Power International
Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. MTNB | 0.00 |
- Matinas BioPharma announced a reorganization via a business combination with GH Power to form Ontario-based GH Power International as the new public parent.
- Transaction targets a NYSE American listing for the combined clean energy and critical materials company; closing expected in Q4 2026.
- GH Power holders expected to own about 91% post-close; Matinas holders about 9% on a fully diluted basis.
- Each Matinas common share expected to convert into 0.1 of a GH Power International common share; options, warrants to roll over.
- Closing conditions include at least USD 15 million PIPE financing, shareholder approvals, Ontario court approvals, Form F-4 effectiveness.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Matinas BioPharma Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260713979715) on July 13, 2026, and is solely responsible for the information contained therein.
